MEDULLARY CARCINOMA OF BREAST
- Medullary carcinoma represents 5 to 7% of invasive breast carcinoma
- It is considered as variant of ductal carcinoma
- Mean age of presentation is 45 -54 years. Patients are relatively younger than ductal carcinoma NOS
- Mammographically – well circumscribed nodule
- Gross features
- Tumor is soft and fleshy like marrow, hence the term medullary (Medulla is Latin word for marrow)
- Smaller size of 2 to 3 cms
- Well circumscribed with distinct margins often resembling benign lesion clinically and mammographically
- Haemorrhage and necrosis are rarely present
- · Microscopic features
- Five classical diagnostic features of Medullary carcinoma are
- Syncytial growth pattern (sheet like) in greater than 75% of tumor area
- Moderate to marked lymphoplasmacytic infiltrate in the stroma. Predominantly T lymphocytic infiltrate is present
- Tumor cells with high nuclear grade and indistinct cell borders
- Noninvasive microscopic circumscription – pushing smooth borders instead of infltrating margins
- High mitotic rate
Medullary carcinoma: Syncitial sheets of tumor cells with peripheral lymphocyte infiltrate (H&E,X50)
Medullary carcinoma: Syncitial sheets of tumor cells with peripheral lymphocyte infiltrate (H&E,X100)
Medullary carcinoma: Syncitial sheets of tumor cells with peripheral lymphocyte infiltrate (H&E,X100)
Medullary carcinoma: Circumscribed tumor with tumor cells arranged in sheets and nests. Periphery of the tumor shows lymphocytic infiltrate (H&E,X50)
Medullary carcinoma: Tumor cells are arranged in cords. Interstitial stroma shows lymphocytic infiltrate (H&E,X100)
Medullary carcinoma: Tumor cells are arranged in cords. Interstitial stroma shows lymphocytic infiltrate (H&E,X100)
Medullary carcinoma: Sheets of tumor cells with hyperchromatic nuclei with nucleoli and indistinct cell borders. Interstitial stroma shows lymphocytic infiltrate (H&E,X100)
Medullary carcinoma: Sheets of tumro cells having pleomorphic round to oval vesicular nuclei with nucleoli and moderate amount of cytoplasm. Interstitial stroma shows lymphocytic infitrate (H&E,X400)
Medullary carcinoma: Sheets of tumro cells having pleomorphic round to oval vesicular nuclei with nucleoli and moderate amount of cytoplasm. Interstitial stroma shows lymphocytic infitrate (H&E,X400)
Medullary carcinoma: Tumor cells having hyperchromatic nuclei of varying sizes. Mononucleated and multinucleated tumor giant cells are present. Interstitial stroma shows lymphocytic infiltrate (H&E,X400)
Medullary carcinoma: Spindling of tumor cells having hyperchromatic nuclei of varying sizes and shapes. Interstitial stroma shows lymphocytic infiltrate (H&E,X100)
Medullary carcinoma: Spindling of tumor cells having hyperchromatic nuclei of varying sizes and shapes. Interstitial stroma shows lymphocytic infiltrate (H&E,X100)
Medullary carcinoma: Tumor cells having round to oval nuclei with prominent nucleoli. Multinucleated tumor giant cells are present (H&E,X400)
Medullary carcinoma: Tumor cells arranged in syncytial pattern with peripheral lymphocytic infiltrate (H&E,X50)
Medullary carcinoma: Tumor cells arranged in syncytial pattern with peripheral lymphocytic infiltrate (H&E,X100)
Medullary carcinoma: Tumor cells showing pleomorphism with peripheral lymphocytic infiltrate (H&E,X100)
·
Medullary carcinoma: Tumor cells showing pleomorphism with peripheral lymphocytic infiltrate (H&E,X200)
Medullary carcinoma: Tumor cells showing pleomorphism with peripheral lymphocytic infiltrate (H&E,X200)
Medullary carcinoma: Tumor cells showing pleomorphism with peripheral lymphocytic infiltrate (H&E,X400)
- Immunohistochemistry
- Tumor cells are P53 positive and HER2/neu negative tumors
- 90% of tumors are ER negative. Only 10% are ER and PR positive
- · Treatment and Prognosis
- Good prognosis
- Treatment is modified radical mastectomy
- The only prognostic factor is axillary lymph nodal status.
References :
1. Robbins and Cotrans: Pathologic basis of diseases.8th edition
2. Fattaneh A Tavassoli, Vincenzo Eusebi. Tumors of mammary gland. AFIP Atlas of tumor pathology. Series 4